Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof | Patent Number 09376397

US 09376397 B2
Application Number14609248
Publication NumberUS 20150141449 A1
Pendency1 year, 5 months, 1 day
Filled DateJan 29, 2015
Priority DateFeb 1, 2010
Publication DateMay 21, 2015
Expiration DateJan 31, 2030
Inventor/ApplicantsJanez Kosmrlj
Zdenko CASAR
Zdenko Casar
ExaminesBALASUBRAMANIAN, VENKATARAMAN
Art Unit1624
Technology Center1600
Assignments
Lek Pharmaceuticals D.d. Sandoz
Current
Lek Pharmaceuticals D.d. SandozNovartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.